These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 17374329)

  • 41. Networking in Europe for special centres of excellence for autoimmune diseases.
    Vasconcelos C; Cervera R
    Lupus; 2009 Sep; 18(10):930-2. PubMed ID: 19671795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions.
    Emmi G; Silvestri E; Squatrito D; Ciucciarelli L; Cameli AM; Denas G; D'Elios MM; Pengo V; Emmi L; Prisco D
    ScientificWorldJournal; 2014; 2014():341342. PubMed ID: 25374937
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment-induced downregulation of antiphospholipid antibodies: effect of rituximab alone on clinical and laboratory features of antiphospholipid syndrome.
    Sciascia S; Naretto C; Rossi D; Bazzan M; Roccatello D
    Lupus; 2011 Oct; 20(10):1106-8. PubMed ID: 21652607
    [No Abstract]   [Full Text] [Related]  

  • 44. Antiphosphatidylethanolamine antibodies and the antiphospholipid syndrome.
    Sanmarco M; Boffa MC
    Lupus; 2009 Sep; 18(10):920-3. PubMed ID: 19671793
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry.
    Avcin T; Cimaz R; Silverman ED; Cervera R; Gattorno M; Garay S; Berkun Y; Sztajnbok FR; Silva CA; Campos LM; Saad-Magalhaes C; Rigante D; Ravelli A; Martini A; Rozman B; Meroni PL
    Pediatrics; 2008 Nov; 122(5):e1100-7. PubMed ID: 18955411
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Antiphospholipid syndrome - an update on diagnosis and treatment].
    Szturmowicz M
    Pneumonol Alergol Pol; 2009; 77(5):460-8. PubMed ID: 19890826
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Multiple sclerosis associated with antiphospholipid syndrome: diagnostic and therapeutic difficulties].
    Ahbeddou N; Ait Ben Haddou E; Hammi S; Slimani C; Regragui W; Benomar A; Yahyaoui M
    Rev Neurol (Paris); 2012 Jan; 168(1):65-9. PubMed ID: 21665238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Criteria for the diagnosis of antiphospholipid syndrome in patients presenting with dermatologic symptoms.
    Kriseman YL; Nash JW; Hsu S
    J Am Acad Dermatol; 2007 Jul; 57(1):112-5. PubMed ID: 17467850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary, secondary, and catastrophic antiphospholipid syndrome: what's in a name?
    Harris EN; Pierangeli SS
    Semin Thromb Hemost; 2008 Apr; 34(3):219-26. PubMed ID: 18720301
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Antiphospholipid antibodies with HCV infection. Innocent proteins or risk factor?].
    Kisiel E; Kryczka W
    Przegl Lek; 2007; 64(7-8):521-4. PubMed ID: 18409357
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiphospholipid syndrome with renal artery embolism: case report.
    Safley DM; McCullough PA
    Rev Cardiovasc Med; 2002; 3(4):196-201. PubMed ID: 12556753
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antiphospholipid antibodies and the antiphospholipid syndrome II: limitations, standardization, and clinical utility of laboratory testing.
    Favaloro EJ; Wong RC
    Semin Thromb Hemost; 2008 Jun; 34(4):309-12. PubMed ID: 18814063
    [No Abstract]   [Full Text] [Related]  

  • 53. [Antiphospholipid syndrome in pregnancy--contemporary opinions concerning pathogenesis and diagnostic criteria].
    Matusiak-Kita M; Murawski M; Gryboś M
    Wiad Lek; 2009; 62(1):21-5. PubMed ID: 19817253
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Urologic damage of the primary antiphospholipid syndrome].
    Fernández Rosado E; Sánchez Rodríguez-Losada J; Alvarez Castelo L; Blanco Diez A; Barbagelata López A; Ponce Diaz-Reixa J; Ruibal Moldes M; Novas Castro S; Chantada Abal V; González Martín M
    Arch Esp Urol; 2004 Sep; 57(7):707-23. PubMed ID: 15536952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Antiphospholipid syndrome: pathophysiology and clinicobiological aspects].
    Ksouri H; Mellouli F; Béjaoui M
    Arch Inst Pasteur Tunis; 2008; 85(1-4):91-105. PubMed ID: 19469420
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiphospholipid antibodies and antiphospholipid syndrome in patients with malignancies: features, incidence, identification, and treatment.
    Miesbach W
    Semin Thromb Hemost; 2008 Apr; 34(3):282-5. PubMed ID: 18720308
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnosis and management of the antiphospholipid syndrome.
    Cohen D; Berger SP; Steup-Beekman GM; Bloemenkamp KW; Bajema IM
    BMJ; 2010 May; 340():c2541. PubMed ID: 20472677
    [No Abstract]   [Full Text] [Related]  

  • 58. Antiphospholipid syndromes in infectious diseases.
    Amin NM
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):131-43, vii-viii. PubMed ID: 18207071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. European attempts for the standardisation of the antiphospholipid antibodies.
    Tincani A; Filippini M; Scarsi M; Galli M; Meroni PL
    Lupus; 2009 Sep; 18(10):913-9. PubMed ID: 19671792
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiac manifestations in antiphospholipid syndrome.
    Soltész P; Szekanecz Z; Kiss E; Shoenfeld Y
    Autoimmun Rev; 2007 Jun; 6(6):379-86. PubMed ID: 17537384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.